Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-10-04
1999-02-09
Wax, Robert A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530383, 530413, 514 8, 514 21, A61K 3514
Patent
active
058696172
ABSTRACT:
The invention provides high and low molecular weight fraction of von Willebrand Factor (vWF), which can be obtained by absorbing vWF to a heparin affinity support followed by eluting the vWF at differing salt concentrations The low molecular weight fraction is predominantly dimers and tetramers, and the high molecular weight fraction is predominantly larger multimers.
REFERENCES:
patent: 5198349 (1993-03-01), Kaufman
patent: 5408039 (1995-04-01), Burnouf-Radosevich et al.
patent: 5506341 (1996-04-01), Newman et al.
Wagner et al., "Inhibition of Disulfide of von Willerbrand Protein by Monensin Results in Small, Functionally Defective Multimers", J. Cell Biol., vol. 101, pp. 112-120, Jul. 1985.
Senogles et al., "von Willerbrand Factor A protein which binds at the cell Surface Interface between Platelets", J. Biol. Chem., vol. 258, No. 20, pp. 12327-12333, Oct. 1983.
Aihara et al., "Two Affinity Immunoelectrophoretic Methods for studying Collagen Interaction with von Willerbrand Factor Antigen", Tohoku J. exp. Med. 1987, vol. 153, pp. 169-177, Aug. 1987.
Baillod et al., "Multimeric Analysis of von Willerbrand Factory by Vertical Sodium Dodecyl Sulphate Agarose Gel Electrophoresis, Vacuum Blotting Technology and Sensitive Visualization by alkaline Phosphatase Anti-Alkaline Phosphatase Complex", Throm. Res. vol. 66, pp. 745-755, 1992.
Bradford, "A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding", Anal. Biochem., vol. 72, pp. 248-254, 1976.
Falkner et al., "High Level Expression of Active Human Prothrombin in a Vaccina Virus Expression System", Throm., vol. 68, No. 2, pp. 119-124, 1992.
Barrett et al., "Large-Scale Production and Purification of a Vaccinia Recombinant-Derived HIV-1 gp160 and Analysis of Its Immunogenicity", Aids Res. and Human Retroviruses, vol. 5, No. 2, 1989.
Laemmli, "Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4", Nature vol. 227, pp. 680-685, Aug. 15, 1970.
Furlan et al., "Triplet structure of von Willerbrand factor reflects proteolytic degradation of high molecular weight multimers", Proc. Natl. Acad. Sci. USA, vol. 90, pp. 7503-7507, Aug. 1993.
Mannheim, Translation of relevant part of Witt Biochemistry of Blood Coagulation and Fibrinolysis, pp. 14-16, 1991.
Putney, AIDS Vaccine and Research and Clinical Trials pp. 219-239, 1990.
Dorner Friedrich
Fischer Bernhard
Mitterer Artur
Immuno Aktiengesellschaft
Longton Enrique D.
Wax Robert A.
LandOfFree
High and low molecular weight fractions of von Willebrand Factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High and low molecular weight fractions of von Willebrand Factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High and low molecular weight fractions of von Willebrand Factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1949388